SYDNEY (Reuters) -Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday, achieving the best first-day trading performance following an IPO in the city in four years.

SYDNEY, April 7 (Reuters) - Chinese biotech firm Duality Biotherapeutics launched an initial public offering (IPO) of up to HK$1.56 billion ($200.7 million) on Monday in Hong Kong, testing ...

[SYDNEY] Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday (Apr 15), after the Chinese firm raised US$213 million in an initial public offering (IPO) launched the day ...